Evidence map›Paper›PMID 38737826›Full record

ArticleTherapeutic advances in drug safety2024

The American Program in Pharmacovigilance (Am2P): a new accredited online training program in pharmacovigilance and pharmacoepidemiology.

Veronique Kugener, Karine Palin, Maribel Salas, Peggy Webster, Abimbola Cole, John Price, Sepideh Habibi, Christa Naboulet, Dona Ely, Pinak Joshi and 1 more

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Therapeutic advances in drug safety, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Veronique KugenerTakeda Pharmaceuticals, Cambridge, MA, USA.
Karine PalinEu2P Programme, Collège Santé, Université de Bordeaux, Bordeaux, France.
Maribel SalasDaiichi Sankyo Inc, Tokyo, Japan.
Peggy WebsterGSK, Cambridge, MA, USA.
Abimbola ColeGSK, Cambridge, MA, USA.
John PriceIndependent PV Consultant, Connecticut, USA.
Sepideh HabibiCRISPR Therapeutics, South Boston, MA, USA.
Christa Naboulet#PEPiTe santé, Collège Santé - Université de Bordeaux, Bordeaux, France.
Dona ElyTakeda, Cambridge, MA, USA.
Pinak JoshiCareDx Inc, Brisbane, California, USA.
Marina A MalikovaSurgical Translational Research Operations and Compliance, Department of Surgery, Boston Medical Center, Boston University, Chobanian and Avedisian School of Medicine, 88 East Newton Street, Collamore Building, Boston, MA 02215-1300, USA.ORCID https://orcid.org/0000-0003-1370-187X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Am2Pcertification in PharmacovigilanceNorth Americaonline educationPharmacovigilance

Identifiers

PMID38737826
PMCPMC11088298

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.